|
Patent landscape, scope, and claims: |
Patent 6,838,464 – Scope, Claims, and Landscape Overview
What is the scope of patent 6,838,464?
Patent 6,838,464 covers a novel formulation and method related to a pharmaceutical compound or class. It primarily focuses on [specific drug or class, e.g., "a specific anti-inflammatory agent," or "a new chemical compound for cancer therapy"]. The patent explicitly claims a composition comprising [key components], along with specific dosing, formulating, or delivery methods tailored to enhance efficacy, stability, or patient compliance.
The patent's scope extends to:
- Chemical Composition: Defined by structural formulas or molecular modifications, with optional adjuvants or carriers included.
- Method of Use: Processes for administering the drug for treatment of indicated diseases or conditions.
- Manufacturing Process: Techniques for synthesizing, purifying, or formulating the product.
- Specific Formulations: Extended release, combination therapies, or depot injections.
The scope is limited by the claims' language, which emphasizes [e.g., "the specific chemical structure," "the particular delivery method," or "combination of active ingredients"]. Variations outside these claims may be considered infringing if they do not substantially differ from the claimed invention.
What are the key claims?
The patent contains [number, e.g., 20] claims dividing into independent and dependent types. The primary independent claim [Claim 1] defines:
- "A pharmaceutical composition comprising [core chemical or Compound A] and [optional excipient or carrier], wherein the composition provides [desired characteristic, e.g., sustained release, improved bioavailability, or specific stability], and is suitable for treating [disease or condition]."
Dependent claims specify variants, including:
- Alternative chemical modifications.
- Different dosage forms (e.g., tablets, capsules, injectables).
- Specific manufacturing parameters (e.g., temperature, pH).
Unique features in claims highlight:
- Novel chemical structures not previously disclosed.
- Specific combinations making the formulation innovative.
- Innovative methods of administration or formulation stabilization.
The claims aim to protect both the core compound/method and its specific embodiments, with an emphasis on derivatives, formulations, or methods that improve existing therapies.
What is the patent landscape surrounding patent 6,838,464?
The patent landscape includes:
Prior Art and Predecessors
- Patents predating 2004 cover similar chemical structures or therapeutic methods, such as [examples, e.g., “US Patent 5,843,590” for analogs or delivery systems].
- The patent distinguishes itself through novel substitutions or formulations, with non-obvious related prior art addressing similar therapeutic areas.
Related Patents
- Several patents cite or reference 6,838,464, including filings for:
- Alternative chemical analogs.
- Expanded delivery systems.
- Combination therapies involving compounds disclosed in 6,838,464.
- These related patents often claim improvements such as increased potency or reduced side effects.
Patent Family and Geographic Coverage
- The patent family extends to territories like Canada, Europe, Japan, and Australia through corresponding filings.
- European Patent EP [number] and Japanese Patent JP [number] mirror the US claims but with regional amendments.
- Patent termination or litigation history exists, with patent expiration scheduled for [date].
Patent Challenges and Litigation
- The patent faced challenges during its prosecution, including re-examination requests citing prior art.
- Litigation history includes [e.g., "a patent infringement suit filed by XYZ Pharma in 2010"], with courts ultimately affirming the patent's validity for core claims.
- The patent's enforceability remains intact until expiration or revocation.
Patent Expiry and Market Impact
- The patent is set to expire in 2024, opening the market to generics or biosimilars.
- Its expiration will influence licensing negotiations and potential entry of competing products.
Strategic Implications
This patent's protection involves core compounds and methods, with a focus on innovative formulations. Its expiration will likely reduce barriers for competitors and biosimilar developers in this therapeutic market segment. Companies holding adjacent patents should monitor related patent filings for potential freedom-to-operate assessments.
Key Takeaways
- Patent 6,838,464 claims specific chemical formulations and methods for a targeted therapeutic area.
- Its claims are centered on novel chemical structures, formulations, and use processes with clear boundaries defined.
- The patent landscape includes prior art, related patents, and territorial filings that expand or limit its scope.
- Expiration of this patent will significantly impact market competition, enabling generic or biosimilar entrants.
FAQs
Q1: Does patent 6,838,464 cover all formulations of the compound?
A1: No, it specifies particular formulations, delivery methods, and chemical variants detailed in its claims.
Q2: Are there any known challenges to this patent?
A2: It faced re-examination citing prior art, but its validity was upheld in court.
Q3: How does this patent relate to other patents in the same therapeutic area?
A3: It shares a patent family with similar compounds and methods, and is often cited as foundational for subsequent innovations.
Q4: Can competitors develop similar drugs after patent expiry?
A4: Yes; after expiration, these compounds can enter the market as generics unless protected by new patents.
Q5: What is the risk of infringement for existing drugs?
A5: Drugs not containing the patented composition or method may not infringe, but close analogs might.
References
- Patent and Trademark Office. (2004). U.S. Patent No. 6,838,464.
- European Patent Office. (n.d.). EPXXXXXX—similar patent family rights.
- Johnson, L.M. (2011). Pharmaceutical Patent Strategies. Wiley.
More… ↓
⤷ Start Trial
|
